Most bought healthcare stocks in Q3 2024
Discover which Healthcare stocks institutional investors added to most aggressively over Q3 2024 versus the prior calendar quarter in our filings. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), TEVA PHARMACEUTICAL-SP ADR (TEVA), RECURSION PHARMACEUTICALS-A (RXRX), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 18,453,544 | $977.3M | 2 | 8 | 3 | 0 | 14 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 6,143,847 | $139.0M | 1 | 2 | 4 | 0 | 8 |
| RXRX | RECURSION PHARMACEUTICALS-A | 4,628,268 | $4.9M | 0 | 2 | 0 | 0 | 3 |
| AVTR | AVANTOR INC | 4,062,947 | $473.3M | 1 | 4 | 5 | 0 | 12 |
| CVS | CVS HEALTH CORP | 3,950,772 | $554.6M | 3 | 7 | 10 | 1 | 21 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,951,234 | -$48.1M | 1 | 3 | 4 | 1 | 8 |
| OPCH | OPTION CARE HEALTH INC | 2,424,147 | $77.4M | 2 | 2 | 1 | 0 | 5 |
| PRVA | PRIVIA HEALTH GROUP INC | 2,291,448 | $49.3M | 1 | 3 | 0 | 0 | 4 |
| SYK | STRYKER CORP | 2,060,689 | $947.2M | 3 | 7 | 6 | 0 | 18 |
| TEM | TEMPUS AI INC | 1,855,459 | $116.3M | 0 | 1 | 0 | 0 | 1 |
| ELEV | ELEVATION ONCOLOGY INC | 1,785,982 | $1.1M | 1 | 0 | 0 | 0 | 1 |
| SOLV | SOLVENTUM CORP | 1,771,557 | $216.9M | 1 | 3 | 3 | 2 | 9 |
| DOCS | DOXIMITY INC-CLASS A | 1,523,807 | $191.5M | 1 | 2 | 1 | 1 | 4 |
| GH | GUARDANT HEALTH INC | 1,507,557 | $31.9M | 2 | 2 | 0 | 0 | 4 |
| NVST | ENVISTA HOLDINGS CORP | 1,465,983 | $70.6M | 1 | 2 | 3 | 0 | 6 |
| ALHC | ALIGNMENT HEALTHCARE INC | 1,464,579 | $39.5M | 0 | 1 | 1 | 0 | 2 |
| WRBY | WARBY PARKER INC-CLASS A | 1,423,134 | $25.6M | 0 | 3 | 1 | 0 | 4 |
| BSX | BOSTON SCIENTIFIC CORP | 1,342,301 | $136.7M | 4 | 6 | 3 | 0 | 14 |
| VREX | VAREX IMAGING CORP | 1,278,739 | $6.3M | 0 | 2 | 2 | 0 | 4 |
| TXG | 10X GENOMICS INC-CLASS A | 1,241,416 | $57.9M | 0 | 2 | 1 | 1 | 4 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,218,100 | $2.5M | 0 | 1 | 0 | 0 | 1 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1,207,600 | $21.3M | 0 | 1 | 0 | 0 | 3 |
| XRAY | DENTSPLY SIRONA INC | 1,188,116 | $61.7M | 1 | 4 | 0 | 0 | 6 |
| MRK | MERCK & CO. INC. | 1,078,855 | $53.3M | 1 | 7 | 11 | 5 | 25 |
| ADMA | ADMA BIOLOGICS INC | 1,046,747 | $44.7M | 0 | 1 | 1 | 0 | 2 |
| NVAX | NOVAVAX INC | 957,407 | $12.1M | 1 | 3 | 1 | 0 | 5 |
| BMY | BRISTOL-MYERS SQUIBB CO | 907,910 | $429.9M | 2 | 10 | 9 | 1 | 22 |
| ASRT | ASSERTIO HOLDINGS INC | 856,309 | $867.8K | 0 | 1 | 0 | 0 | 1 |
| ABSI | ABSCI CORP | 833,734 | $7.3M | 0 | 1 | 0 | 0 | 1 |
| MYGN | MYRIAD GENETICS INC | 805,481 | $28.2M | 1 | 1 | 0 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | 797,309 | $219.8M | 2 | 8 | 3 | 0 | 16 |
| BAYRY | BAYER AG-SPONSORED ADR | 785,085 | $12.9M | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 774,517 | -$197.1M | 0 | 8 | 1 | 2 | 9 |
| FGEN | FIBROGEN INC | 753,140 | $300.8K | 1 | 0 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 726,200 | $2.7M | 0 | 1 | 0 | 0 | 1 |
| CNC | CENTENE CORP | 658,806 | $71.1M | 3 | 2 | 4 | 0 | 9 |
| OGN | ORGANON & CO | 650,699 | $2.0M | 2 | 5 | 1 | 0 | 9 |
| MNKD | MANNKIND CORP | 637,920 | $4.2M | 0 | 1 | 1 | 0 | 3 |
| PSNL | PERSONALIS INC | 625,437 | $34.5M | 0 | 1 | 1 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 624,296 | -$8.5M | 0 | 2 | 1 | 1 | 3 |
| TALK | TALKSPACE INC | 561,600 | $866.9K | 1 | 1 | 0 | 0 | 2 |
| NTRA | NATERA INC | 521,621 | $78.5M | 1 | 6 | 0 | 0 | 7 |
| KZR | KEZAR LIFE SCIENCES INC | 518,600 | $535.8K | 0 | 1 | 0 | 0 | 1 |
| NVRO | NEVRO CORP | 505,819 | -$3.6M | 0 | 1 | 1 | 0 | 2 |
| HCA | HCA HEALTHCARE INC | 497,240 | $657.0M | 3 | 5 | 4 | 1 | 12 |
| CPRX | CATALYST PHARMACEUTICALS INC | 485,908 | $19.2M | 1 | 2 | 0 | 0 | 3 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 485,180 | $374.3K | 0 | 1 | 0 | 0 | 1 |
| AUPH | AURINIA PHARMACEUTICALS INC | 466,313 | $4.9M | 0 | 2 | 1 | 0 | 4 |
| BLUE | BLUEBIRD BIO INC | 451,168 | -$230.6K | 0 | 2 | 1 | 0 | 4 |
| ACRS | ACLARIS THERAPEUTICS INC | 448,500 | $562.6K | 0 | 1 | 0 | 0 | 2 |